Recommended
More Related Content
What's hot
What's hot (20)
Similar to PESTLE Analysis of Sun Pharma Ltd (Business Environment Project)
Similar to PESTLE Analysis of Sun Pharma Ltd (Business Environment Project) (20)
Recently uploaded
Recently uploaded (20)
PESTLE Analysis of Sun Pharma Ltd (Business Environment Project)
- 1. SUN PHARMA GROUP MEMBERS ALISTER LOPES - 08 ALSTON DIAS – 09 ANKITA PATIL - 16 ANOSHKA ALMEIDA - 18 CLEMENCE ANDRADES - 28 KASIA FURTADO - 54
- 2. INTRODUCTION: • Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company. • Offers formulations in various therapeutic areas. • Establishment of Sun Pharmaceutical. • Largest chronic prescription company in India . • Sales of Sun Pharmaceutical.
- 4. POLITICAL FACTORS: • Political stability in the existing markets. • Importance of local governments in India. • Changing policies with new government. • Governance System
- 5. ECONOMIC FACTORS: • Skill level of workforce in India market • Economic Performance of India • Availability of core infrastructure in India • Inflation rate • Efficiency of financial markets in India
- 6. SOCIAL FACTORS: • Access to essential services • Power structure • Education level • Leisure interests • Gender roles • Societal norms and hierarchy
- 7. TECHNOLOGICAL FACTORS: • Need for new technology • Lowering cost of production • Latest technology based • Intellectual property rights and patents • Research and development
- 8. ENVIRONMENTAL FACTORS: • Environmental norms. • Customer activism • Recycling • Extreme weather • Renewable technology
- 9. LEGAL FACTORS: • Health and safety norms. • Legal protection • Data protection laws • Environment Laws and guides
- 10. CONCLUSION: From the following PESTLE analysis of SUN PHARMA we analyze some key areas where improvements are possible for SUN pharma to achieve a stronger position in the market which are as follows: • Maintain leadership in existing markets through focus on innovative solutions. • Focus on developing complex products across multiple dosage forms. • Continuously enhance systems, processes, human capabilities to ensure compliance with global regulatory standards. • Focus on improving ROCE. • Retain current employees for continual growth.
- 11. THANK YOU!!!